Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Atractylodes lancea root oil is a plant-derived essential (volatile) oil extracted from the rhizome of Atractylodes lancea, a traditional Chinese medicinal herb. The main bioactive components of this essential oil are sesquiterpenes such as hinesol, β-eudesmol, atractylon, and atractylodin. These compounds have demonstrated various pharmacological activities in preclinical studies, including anti-inflammatory, antitumor (notably against cholangiocarcinoma), analgesic, antiviral, gastrointestinal-protective effects, and promotion of chondrogenic differentiation in mesenchymal stem cells. The mechanism of action is believed to involve modulation of inflammatory mediators (such as TNF-alpha and interleukins), inhibition of cancer cell growth via induction of apoptosis and suppression of angiogenesis, as well as regulation of gastrointestinal motility. Atractylodes lancea root oil is used in some over-the-counter topical products but is not an approved pharmaceutical drug for any indication[2][3][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Atractylodes lancea root oil.